Humoral Immune Response in IBD Patients Three and Six Months after Vaccination with the SARS-CoV-2 mRNA Vaccines mRNA-1273 and BNT162b2
Vollenberg R*, Tepasse P-R*, Kühn JE, Hennies M, Strauss, M Rennebaum F, Schomacher T, Boeckel G, Lorentzen E*, Bokemeyer A*, Nowacki TM* (*equally contributed)
Research article (journal) | Peer reviewedDetails about the publication
Journal: Biomedicines
Volume: 10
Issue: 171
Status: Published
Release year: 2022 (13/01/2022)
Language in which the publication is written: English
Link to the full text: https://www.mdpi.com/2227-9059/10/1/171
Keywords: SARS-CoV-2; mRNA-Impfungen; Impfantwort bei IBD; Serokonversion; COVID-19
Authors from the University of Münster
| Boeckel, Göran Ramin | Medical Clinic of Internal Medicine D (Nephrology and Rheumatology) (Med D) |
| Hennies, Marc Tim | Institute of Molecular Virology |
| Kühn, Joachim | Institute of Molecular Virology |
| Lorentzen, Eva | Institute of Molecular Virology |
| Nowacki, Tobias Max | Medical Clinic of Internal Medicine B: Gastroenterology and Metabolic Disorders (Med B) |
| Rennebaum, Florian | Medical Clinic of Internal Medicine B: Gastroenterology and Metabolic Disorders (Med B) |
| Schomacher, Tina | Medical Clinic of Internal Medicine B: Gastroenterology and Metabolic Disorders (Med B) |
| Tepasse, Phil-Robin | Medical Clinic of Internal Medicine B: Gastroenterology and Metabolic Disorders (Med B) |
| Vollenberg, Richard | Medical Clinic of Internal Medicine B: Gastroenterology and Metabolic Disorders (Med B) |